HMGB1 and liver dysplastic nodule: Additionally, dagliazine has been shown to exert therapeutic effects on renal inflammation, lipid deposition, oxidative stress, and fibrosis by inhibiting HMGB1 expression and stimulating autophagy in diabetic mice, thereby providing a new therapeutic target for DN (120).